Home Events

KFF Events

featured events

Developments in Prescription Drug Pricing under the Second Trump Administration

Three experts joined Larry Levitt, executive vice president for health policy at KFF, for a “Health Wonk Shop” discussion about the latest developments in prescription drug pricing and what they mean for drug manufacturers, patients and public and private health insurance programs. Register to attend this virtual event.

How the Trump Administration and Congress Are Reshaping the ACA’s Marketplaces

Through regulations and the House budget reconciliation bill, significant changes are being considered by Congress and the Trump Administration for how the Affordable Care Act’s health insurance Marketplaces would work. To examine how these changes could reshape the ACA’s Marketplaces, KFF held a virtual briefing featuring leaders from two state-based Marketplaces to get perspectives from the field.

KFF's Conference Centers

KFF operates public meeting spaces in San Francisco and Washington D.C. that are available for use free of charge to nonprofit organizations working on health care and public policy. Learn more.

View the Latest: Events

Filter

List Grid

21 - 30 of 461 Results

  • Marketing Medicare – How Health Insurers and Brokers Use TV Ads to Attract Enrollees

    Event Date:
    Event

    KFF held a web event on September 20, 2023 to discuss Medicare marketing practices in advance of the open enrollment period, which begins Oct. 15. As part of the event, KFF released a new analysis of television ads that aired during last year’s open enrollment season and share insights from focus groups with enrollees about their perceptions of the marketing efforts.

  • Will Insurance Cover Over-the-Counter Contraceptive Pills? A Discussion of Coverage Options and Challenges

    Event Date:
    Event

    The U.S. Food and Drug Administration recently approved Opill—the first over-the-counter daily oral contraceptive pill in the United States. Beginning in early 2024, people will be able to purchase Opill without a prescription, expanding options for contraceptive access across the country. On September 15, 2023, a panel of experts joined Laurie Sobel, associate director for KFF’s Women’s Health Policy program, to explore approaches to covering over-the-counter oral contraception without a prescription. The panel discussed lessons learned from the implementation of private insurance or Medicaid coverage from the perspectives of various stakeholders.

  • Thinking Big in Public Health, Inspired by the End of Smallpox

    Event Date:
    Event

    Watch an online conversation led by Céline Gounder, a physician-epidemiologist and the host of “Eradicating Smallpox,” Season 2 of the “Epidemic” podcast. The docuseries explores the parallels between the campaign to end a centuries-old disease and the challenges public health faces today.

  • Probing the Legal Arguments in the Drug Industry’s Challenges to Medicare Drug Price Negotiations

    Event Date:
    Event

    With the Biden administration’s announcement of the first 10 drugs to be negotiated for Medicare as part of the Inflation Reduction Act (IRA), an array of legal challenges from the pharmaceutical industry is potentially the biggest obstacle to implementation. On Tuesday, September 12, two legal experts and a health policy expert joined Larry Levitt, executive vice president for health policy at KFF, for a 45-minute discussion about the legal issues underpinning these lawsuits and how they intersect with the policy goals of the legislation.

  • New Weight Loss Drugs Raise Issues of Coverage, Cost, Access and Equity

    Event Date:
    Event

    New weight loss drugs, such as Novo Nordisk’s Ozempic and Wegovy (semaglutide) and Eli Lilly’s Mounjaro (tirzepatide), could be transformative for people who struggle with obesity and obesity-related medical conditions, but there are major questions to consider related to insurance coverage, the cost of the drugs, and who has access. On August 4, three experts joined Larry Levitt, executive vice president for health policy at KFF, for a 45-minute “Health Wonk Shop” discussion about the questions surrounding what a new generation of weight loss drugs means for patients and payers.

  • Probing the Power and Practices of Pharmacy Benefit Managers

    Event Date:
    Event

    Pharmacy benefit managers (PBMs) are increasingly scrutinized intermediaries in the U.S. health care system, negotiating discounts on prescription medications for health insurers and employers while collecting rebates from drugmakers. On June 14, two experts joined KFF’s The Health Wonk Shop and series moderator Larry Levitt in a 45-minute discussion about the power and practices of PBMs.

  • Medicaid Work Requirements

    Event Date:
    Event

    Three experts joined series moderator Larry Levitt in a discussion about work and reporting requirements in public programs such as Medicaid, their effects on enrollment and employment, and what we can expect on the state and federal levels regarding the future of Medicaid work requirements.

  • A Conversation with CDC Director Dr. Rochelle Walensky on Meeting Our Public Health Challenges

    Event Date:
    Event

    KFF hosted CDC Director Dr. Rochelle Walensky for a discussion focused on the status of COVID-19, the CDC’s priorities for the future, including the agency’s recent reorganization and other potential reforms, and how CDC is considering the health implications of climate change. Dr. Drew Altman, president and CEO of KFF, made introductory remarks. Dr. Jen Kates, senior vice president and director of KFF’s work on global health and HIV policy, moderated a discussion with Dr. Rochelle Walensky and Dr. Judy Monroe, CDC Foundation president and CEO, who discussed the future of public health as well as the role of public-private partnerships.

  • Unpacking the Controversy Over Medicare Advantage

    Event Date:
    Event

    Medicare Advantage is the rapidly growing private plan alternative to traditional Medicare that provides coverage to approximately half of Medicare beneficiaries. On Tuesday, March 21, three experts joined series moderator Larry Levitt in a 45-minute discussion on Medicare Advantage, addressing such questions as: What has driven the growth in Medicare Advantage enrollment? What are the implications of enrollment being concentrated in a few insurance firms? Is the federal government overpaying plans? What would the new rules and proposed changes do, and how would they affect beneficiaries?

  • How are State Medicaid Programs Approaching the Unwinding of the Federal Continuous Enrollment Provision?

    Event Date:
    Event

    KFF estimates that enrollment in Medicaid and the Children’s Health Insurance Program (CHIP) will have grown by 23.3 million enrollees, to nearly 95 million, by the end of March, when the federal continuous enrollment provision expires. On Thursday, March 16, 2023, KFF hosted an hour-long web briefing focused on how state Medicaid programs are approaching this unwinding of the continuous enrollment provision. States’ existing enrollment and renewal procedures and their differing approaches to the unwinding will have major impacts on Medicaid enrollees, state spending, and broader health coverage trends.